催產素製劑市場：依適應症、給藥途徑、原料、最終使用者和地區分類。

Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin, By End User, and By Region

出版日期: 2026年04月27日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，催產素市值將達到 1.607 億美元，到 2033 年將達到 2.754 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 8.0%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1.607億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.00%	2033年市場規模預測：	2.754億美元

催產素製劑可經由靜脈或肌肉注射給藥，用於引產過程中促進子宮收縮，以利正常分娩，並控制產後出血。催產素有助於預防和治療產後出血。催產素也用於控制產後出血。它也可以與其他藥物或手術合併使用以終止懷孕。催產素屬於一類稱為催產素激素的藥物。其作用機轉是刺激子宮收縮。催產素以溶液（液體）形式提供，由醫生或醫護人員在醫院或診所透過靜脈（注射靜脈）或肌肉（注射肌肉）給藥。當使用催產素注射劑引產或促進子宮收縮時，通常在醫院醫護人員的監督下進行靜脈注射注射。根據美國婦產科醫師學會（ACOG）的建議，預防性使用子宮收縮促進劑可預防子宮功能不全。此外，預計在預測期內，引產率的上升將推動全球催產素市場的成長。

市場動態

主要市場參與者正致力於採取夥伴關係與收購等成長策略，進而推動子宮收縮藥物的研發，進而促進全球催產素市場的成長。例如，2022年2月，臨床階段生物製藥公司Tonix Pharmaceuticals Holding Corp.宣布，已與法國國家健康與醫學研究院（Inserm）旗下私人子公司Inserm Transfert以及Inserm Transfer（代表Inserm和艾克斯-馬賽大學）簽署委託研究協議，共同研究催產素在普拉德-威利模型中的基因修飾模型。普拉德-威利症候群是一種罕見的遺傳性疾病，會導致成人和新生兒出現不同的但相關的病理性飲食障礙。在成人中，普拉德-威利症候群會導致神經性貪食症，即病理性過度進食，進而導致肥胖和其他併發症，且死亡率較高。普拉德-威利症候群會導致新生兒吸吮功能受損，但催產素治療可以使其恢復正常。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球催產素製劑市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
全球催產素製劑市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球催產素市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第9章競爭情勢

公司簡介
- Fresenius Kabi AG
- Biofutura SpA
- Baxter Healthcare Corporation
- Pfizer Inc.
- Ferring BV
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Abbott
- AdvaCare Pharma
- EVER Pharma

第10章

參考
調查方法

簡介目錄

Product Code: CMI3354

Oxytocic Pharmaceuticals Market is estimated to be valued at USD 160.7 Mn in 2026 and is expected to reach USD 275.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 160.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.00%	2033 Value Projection:	USD 275.4 Mn

Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.

Market Dynamics

The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Universite to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market

Detailed Segmentation:

Global Oxytocic Pharmaceuticals Market, By Indication (Revenue, USD Mn, 2021 - 2033)
Abortion Induced Incomplete
Inevitable Abortion
Postpartum Hemorrhage
Labor Induction
Labor Arrest
Global Oxytocic Pharmaceuticals Market, By Route of Administration:
Intramuscular
Intravenous Injection/Infusion
Global Oxytocic Pharmaceuticals Market, By Source of Origin:
Synthetic Oxytocin
Natural Oxytocin (Animal Pituitary Extract)
Global Oxytocic Pharmaceuticals Market, By End User:
Hospitals
Maternity Clinics
Global Oxytocic Pharmaceuticals Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
Fresenius Kabi AG *
Biofutura SpA
Baxter Healthcare Corporation
Pfizer Inc.
Ferring B.V.
Abbott.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Abbott
AdvaCare Pharma
EVER Pharma

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Oxytocic Pharmaceuticals Market, By Indication, 2021 - 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

5. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2021 - 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)

6. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2021 - 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Synthetic Oxytocin
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

7. Global Oxytocic Pharmaceuticals Market, By End User, 2021 - 2033 (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033(%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
Maternity Clinics
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)

8. Global Oxytocic Pharmaceuticals Market, By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033(%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
North America
- Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Indication, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Mn)
  - South Africa
  - Central Africa
  - North Africa

9. Competitive Landscape

Company Profiles
- Fresenius Kabi AG
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Biofutura SpA
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Baxter Healthcare Corporation
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ferring B.V.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- AdvaCare Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- EVER Pharma
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies